Bacterial DNA and endothelial damage in haemodialysis patients

Nephrol Dial Transplant. 2008 Nov;23(11):3635-42. doi: 10.1093/ndt/gfn308. Epub 2008 May 29.

Abstract

Background: An increased percentage of CD14+CD16+ activated monocytes have been reported in peripheral blood from haemodialysis patients. The aim of this study is to investigate if a mild stimulus such as bacterial DNA (CpG-ODNs) contamination may induce an inflammatory response in CD14+CD16+ monocytes from haemodialysis patients and to value the biological consequences of this inflammatory response on endothelial cell damage.

Methods: Circulating mononuclear cells from 20 haemodialysis patients and 15 healthy subjects were studied. CD14+CD16+ and the toll-like receptor 9 (TLR-9) expression were assessed by flow cytometry. Cell culture inserts were used to evaluate the effect of CD14+CD16+ and CpG-ODNs on endothelial cell apoptosis (measured by Tunnel). Intracellular cytokines were measured by Cytometric methods. NF-kappaB, p38 MAPK, c-Jun PI3K and MEK1/2 activity were modified by specific peptides.

Results: At baseline, CD14+CD16+ have an increased expression of cytoquines and TLR-9. CpG-ODNs caused the production and release of cytoquines in CD14+CD16+, but not in CD14++ monocytes. This inflammatory response was mediated by intracellular signalling dependent on NF-kappaB, p38 MARK or c-Jun PI3K but not by MEK1/2 activation. The results of the present study also demonstrate that the inflammatory response induced by the stimulation of CD14+CD16+ by CpG DNA resulted in endothelial cell apoptosis.

Conclusions: The results of the present study demonstrate that in haemodialysis patients there is a subpopulation of pre-activated monocytes that can be stimulated by contaminant bacterial DNA. These activated cells produce and release inflammatory factors that may cause endothelial injury.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Apoptosis / drug effects*
  • Case-Control Studies
  • Cells, Cultured
  • Cytokines / metabolism
  • DNA, Bacterial / pharmacology*
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / pathology*
  • Female
  • Humans
  • Kidney Diseases / pathology*
  • Kidney Diseases / therapy*
  • Lipopolysaccharide Receptors / metabolism
  • Male
  • Middle Aged
  • Monocytes / drug effects
  • Monocytes / immunology
  • Monocytes / pathology
  • NF-kappa B / metabolism
  • Oligodeoxyribonucleotides / pharmacology*
  • Phosphatidylinositol 3-Kinases / metabolism
  • Receptors, IgG / metabolism
  • Renal Dialysis*
  • Toll-Like Receptor 9 / metabolism
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • CPG-oligonucleotide
  • Cytokines
  • DNA, Bacterial
  • Lipopolysaccharide Receptors
  • NF-kappa B
  • Oligodeoxyribonucleotides
  • Receptors, IgG
  • TLR9 protein, human
  • Toll-Like Receptor 9
  • Phosphatidylinositol 3-Kinases
  • p38 Mitogen-Activated Protein Kinases